phase readout
saveNCT06045975: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
ACTIVE_NOT_RECRUITINGupdated 9d ago
community read0 votes
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: HCC - Hepatocellular Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that